In a group of 79 patients with pathogenic germline heterozygous mutations in PTEN (Fig 1, A), 43% present with autoimmunity, lymphoid hyperplasia, or both (autoimmunity in 27% and lymphoid hyperplasia in 24% of patients; Fig 1, B, and see Table E1). This evidence concerns the gene PTEN and Autoimmunity.